24/7 Patient Assistance: 760-405-8205

Vamsi Kota, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Vamsi Kota is a medical oncologist from Atlanta, Georgia and he works at several hospitals in the area, such as Emory University Hospital and Southern Regional Medical Center. He got his diploma from Armed Forces Medical College Pune and did his residency program in Internal Medicine and a fellowship program in Hematology/Oncology at Medical College of Georgia. The doctor is certified in Hematology, Internal Medicine, Medical Oncology and has an experience of more than 20 years.

  • Education & Training


    Armed Forces Medical College Pune

    Medical School


    Medical College of Georgia



    Medical College of Georgia


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Emory University Hospital

    Languages: English/Spanish

    (404) 712–2000

    1364 Clifton Road NE

    Atlanta, Georgia 30322-1102

    Read More
  • Publications & Memberships

    Dr. Vamsi Kota has contributed to 3 publications.

    Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?

    Kong, J. H.,Winton, E. F.,Heffner, L. T.,Chen, Z.,Langston, A. A.,Hill, B.,Arellano, M.,El-Rassi, F.,Kim, A.,Jillella, A.,Kota, V. K.,Bodó, I.,Khoury, H. J.; Cancer. 2017 Feb 28.

    See more >>

    Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.

    Hartranft ME, Clemmons AB, DeRemer DL, Kota V; J Oncol Pharm Pract. 2017-01-01.

    See more >>

    Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?

    DeFilipp Z, Langston AA, Chen Z, Zhang C, Arellano ML, El Rassi F, Flowers CR, Kota VK, Al-Kadhimi Z, Veldman R, Jillella AP, Lonial S, Waller EK, Khoury HJ; Clin Lymphoma Myeloma Leuk. 2016-08-01.

    See more >>